<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03851770</url>
  </required_header>
  <id_info>
    <org_study_id>2018/07NOV/416</org_study_id>
    <nct_id>NCT03851770</nct_id>
  </id_info>
  <brief_title>Laryngeal Motor Evoked-potentials as a Biomarker of Vagus Nerve Stimulation in Epileptic Patients</brief_title>
  <acronym>NEURO-LARYNX</acronym>
  <official_title>NEURO-LARYNX:Laryngeal Motor Evoked-potentials as a Biomarker of Vagus Nerve Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to record and characterize larynx evoked motor potentials induced
      by vagus nerve stimulation. This study will include 10 adult patients implanted with a Vagus
      nerve stimulator, followed at the Center for Refractory Epilepsy at Cliniques St Luc. The
      inclusion criteria are: (1) patient aged between 18 and 65 years ; (2) cervical VNS device
      (Cyberonics, Houston, TX, USA) implanted for at least 6 months, (3) normal electrode
      impedance of the electrode. Exclusion criteria are (1) presence of a concomitant laryngeal
      pathology or recurrent laryngeal nerve damage, independent from VNS ; (2) important VNS side
      effects reported by the patient, such as severe dyspnea (grade III-IV) or severe pain in the
      neck/ear region.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 27, 2018</start_date>
  <completion_date type="Anticipated">September 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients participating will be asked to come to the Neurophysiology Department of Saint Luc Clinic to peform the laryngeal evoked motor potential.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Laryngeal motor evoked potential (LMEP)</measure>
    <time_frame>the LMEP is recorded for 60 minutes from the moment the patient arrives to the clinic to perform the test</time_frame>
    <description>Characteristics of the laryngeal motor evoked potential Threshold : the mA of current output necessary for evoking the LMEP Latency : the time between the negative peak of the stimulation artifact and the first positive deflection of the LMEP Amplitude : the difference in μV between the lowest negative and the highest positive peak of the LMEP Duration : the time between the first positive deflection of LMEP and the return to the noise level Dose- response curve: the relation between increasing intensity of vagal nerve stimulation and amplitude of the LMEP</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>refractory epilepsy patients</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All patients belong to the refractory epilepsy group. Intervention: Characterization of Vagus nerve stimulation: Evoked potentials (EP) are recorded using an EEG/EP digital acquisition system</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Characterization of Vagus nerve stimulation</intervention_name>
    <description>Characterization of Vagus nerve stimulation induced larynx evoked motor potential. Patients participating in the study will be asked to come to perform the experiment (duration maximum 1 hour) at the Neurophysiology Department of Saint Luc .</description>
    <arm_group_label>refractory epilepsy patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients aged between 18 and 65 years

          -  Vagus nerve stimulation implanted for at least 6 months

          -  No impedance issues with the VNS electrode

        Exclusion Criteria:

          -  presence of a concomitant laryngeal pathology or RLN damage, independent from vagus
             nerve stimulation

          -  important side effects of the VNS reported by the patient such as dyspnea, pain in
             neck/ear region and gastrointestinal complaints.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Riëm EL TAHRY, Prof</last_name>
    <phone>+322 764 28 55</phone>
    <email>riem.eltahry@uclouvain.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cliniques Universitaires St Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Riem EL TAHRY, Prof.</last_name>
      <phone>+322764 28 55</phone>
      <email>riem.eltahry@uclouvain.be</email>
    </contact>
    <contact_backup>
      <last_name>Simone VESPA, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 21, 2019</study_first_submitted>
  <study_first_submitted_qc>February 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2019</study_first_posted>
  <last_update_submitted>February 21, 2019</last_update_submitted>
  <last_update_submitted_qc>February 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Epilepsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

